Formulary Search Results for: CALCIUM AND VITAMIN D
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
- The treatment of HIV infection is restricted to use by HIV specialists.
- Use in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults at high risk is restricted to specialist use only by consultants in sexual health and infectious disease consultants.
Prescribing Notes:
Preferred preparation for PrEP in NHSGGC.
Non-Formulary indications:
- Treatment of HIV-1 infected adolescents aged 12 to <18 years with nucleoside reverse transcriptase inhibitor resistance or toxicities precluding the use of first-line agents
8.2.5 Immunomodulating drugs used in Multiple Sclerosis - View Category
Restrictions:
Restricted to specialist use for the treatment of relapsing remitting multiple sclerosis in accordance with local guidelines.
8.2.5 Immunomodulating drugs used in Multiple Sclerosis - View Category
Restrictions:
The treatment of adult patients with relapsing remitting multiple sclerosis is restricted to specialist use in accordance with local guidelines.
12.1.2 Otitis media - View Category
Restrictions:
Restricted to use in the treatment of acute otitis media in patients with tympanostomy tubes (AOMT).
9.6.4 Vitamin D - View Category
Prescribing Notes:
Domnisol® is a monthly preparation and could be prescribed for patients where monthly administration would be advantageous. Domnisol® currently is associated with an acquisition cost advantage compared to daily colecalciferol (September 2024).
4.1.1.2 Hypnotics for chronic insomnia - View Category
Restrictions:
Restricted to use in patients where sleep hygiene advice has been unsuccessful and the use of cognitive behavioural therapy for insomnia (CBT-I) has failed or for whom CBT-I is unsuitable or unavailable.
Prescribing Notes:
- For the treatment of adult patients with chronic insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
- Sleepio® is a six-week programme based on CBT-I. Sleepio® is used to treat insomnia and is available free on the NHS. For more information visit Sleep | NHS inform
6.1.1.2 Intermediate- and long-acting insulins - View Category
Restrictions:
Restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes. Restricted to use in accordance with local guidance which includes information on preferred alternative options.
Prescribing Notes:
Note: Insulin degludec is available in two strengths and caution should be taken in prescribing, dispensing and administration to ensure the correct strength is received.
13.2.6 Bath and Shower Emollients - View Category
Restrictions:
Restricted to use only when skin is infected or if infection is a frequent complication (e.g. folliculitis or secondary infection of eczema).
Prescribing Notes:
Not for prolonged use unless clinically indicated.